[Pharmacokinetic profile of a slow-release ketoprofen preparation]. 1983

B Flouvat, and A Stheneur, and P Massias

Kinetics of ketoprofen release in man from a sustained-release preparation (150 mg) and from capsules (3 X 50 mg) were studied comparatively in 10 healthy adults. Bioavailability of the slow-release preparation is similar to that of capsules : surfaces under the serum concentration curves and urinary elimination were found to be identical. In the sustained-release preparation the immediately available layer (75 mg) ensures achievement of maximal serum concentrations amounting to 59% of those obtained with capsules, after the same time interval. The slow-release layer (75 mg) produces higher serum concentrations from the third hour on, justifying administration of the formulation in two daily doses.

UI MeSH Term Description Entries
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010666 Phenylpropionates Derivatives of 3-phenylpropionic acid, including its salts and esters.
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

B Flouvat, and A Stheneur, and P Massias
January 1992, European journal of clinical pharmacology,
B Flouvat, and A Stheneur, and P Massias
December 1985, British journal of clinical pharmacology,
B Flouvat, and A Stheneur, and P Massias
January 1983, Arzneimittel-Forschung,
B Flouvat, and A Stheneur, and P Massias
June 1990, The New Zealand medical journal,
B Flouvat, and A Stheneur, and P Massias
July 1988, International journal of clinical pharmacology, therapy, and toxicology,
B Flouvat, and A Stheneur, and P Massias
July 1986, Clinical and experimental pharmacology & physiology,
B Flouvat, and A Stheneur, and P Massias
July 1990, Epilepsy research,
B Flouvat, and A Stheneur, and P Massias
January 1994, Calcified tissue international,
B Flouvat, and A Stheneur, and P Massias
September 1989, The Japanese journal of psychiatry and neurology,
B Flouvat, and A Stheneur, and P Massias
December 1981, Journal of clinical and hospital pharmacy,
Copied contents to your clipboard!